GV20 Therapeutics is the US branch of GV20 Oncotherapy. The company utilizes high throughput functional genomics and AI approaches to identify novel cancer immunology drug targets, and discover and develop effective antibody drugs in cancer. GV20's proprietary antibody drug discovery engine has helped establish a solid portfolio of immuno-oncology antibody drug candidates for cancer treatment.

Pharmaceutical

GV20 Therapeutics

Shirley Liu

Xihao Hu

Wei Yang

Huawei Qiu

Xingfeng Bao

Jie Chen

Karim Benhadji

Sherlock Hu

Ying Gong

Ted Xiao

GV20 Therapeutics' Founding Team includes Shirley Liu.

Founding Team

CEO and Executive Team

Leadership Team

Board of Directors

Founding Team

About

Team members

Other teams at GV20 Therapeutics

CEO and Executive Team

Leadership Team

Board of Directors